Participation of allergic mechanisms in formation of irritable bowel syndrome
Abstract
The active development of research in recent years has revealed new aspects in the formation of irritable bowel syndrome. More recently, the vast majority of research has been devoted to the development of psychosomatic mechanisms of functional disease. Conducting an active scientific research has revealed a greater incidence of allergic rhinitis, bronchial asthma in patients with irritable bowel syndrome, increased serum immunoglobulin E of patients, as well as a positive response to the anti-allergic treatment, which confirms the participation of allergy in the formation of disease.
About the Authors
V. A. Akhmedov
Omsk State Medical University
Russian Federation
Russian Federation
O. V. Gaus
Omsk State Medical University
Russian Federation
Russian Federation
References
1. Camilleri M., Lasch K., Zhou W. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. // Am. J. Physiol. Gastrointest. Liver Physiol.- 2012.- Vol. 303.- P. 775-785.
2. Ortiz-Lucas M., Saz-Peiró P., Sebastian-Domingo J. J. Irritable bowel syndrome immune hypothesis. Part one: the role of lymphocytes and mast cells. // Rev. Esp. Enferm. Dig. - 2010.- Vol. 102.- P. 637-647.
3. Walker M. M., Warwick A., Ung C., Talley N. J. The role of eosinophils and mast cells in intestinal functional disease. // Curr Gastroenterol. Rep.- 2011.- Vol. 13.- P. 323-330.
4. Zanini B., Lanzarotto F., Villanacci V. et al. Clinical expression of lymphocytic duodenosis in «mild enteropathy» celiac disease and in functional gastrointestinal syndromes. // Scand. J. Gastroenterol.- 2014.- Vol. 49.- P. 794-800.
5. Vicario M., Gonzalez-Castro A.M., Martinez C. et al. Increased humoral immunity in the jejunum of diarrhea predominant irritable bowel syndrome associated with clinical manifestations. // Gut.- 2015.- Vol. 64 (9). - P. 1379-1388.
6. Yazar A., Atis S., Konca K. et al. Respiratory symptoms and pulmonary functional changes in patients with irritable bowel syndrome. // Am. J. Gastroenterol.-2001.- Vol. 96.- P. 1511-1516.
7. Powell N., Huntley B., Beech T. et al. Increased prevalence of gastrointestinal symptoms in patients with allergic disease. // Postgrad Med. J.- 2007.- Vol. 83.- P. 182-186.
8. Cole J. A., Rothman K.J., Cabral H. J. et al. Incidence of IBS in a cohort of people with asthma. // Dig. Dis. Sci. - 2007.- Vol. 52.- P. 329-335.
9. Huerta C., Garcia Rodriguez L.A., Wallander M.A., Johansson S. Risk of irritable bowel syndrome among asthma patients. // Pharmacoepidemiol Drug Saf.-2002.-Vol. 11.-P. 31-35.
10. Panicker R., Arifhodzic N., Al Ahmad M., Ali S. A. Association and symptom characteristics of irritable bowel syndrome among bronchial asthma patients in Kuwait. // Ann. Thorac. Med.-2010.- Vol. 5.- P. 37-42.
11. Hunskar G. S., Langeland N., Wensaas K. A. et al. The impact of atopic disease on the risk of post-infectious fatigue and irritable bowel syndrome 3 years after Giardia infection. A historic cohort study. // Scand. J. Gastroenterol.- 2012.- Vol. 47.- P. 956-961.
12. Tobin M. C., Moparty B., Farhadi A. et al. Atopic irritable bowel syndrome: a novel subgroup of irritable bowel syndrome with allergic manifestations. // Ann. Allergy Asthma Immunol.-2008.- Vol. 100. - P. 49-53.
13. Jones M. P., Walker M.M., Ford A. C., Talley N. J. The overlap of atopy and functional gastrointestinal disorders among 23,471 patients in primary care. // Aliment. Pharmacol. Ther. - 2014.- Vol. 40.- P. 382-391.
14. Olén O., Neuman A., Koopmann B. et al. Allergy-related diseases and recurrent abdominal pain during childhood - a birth cohort study. // Aliment Pharmacol Ther.- 2014.- Vol. 40.- P. 1349-1358.
15. Smith M. A., Youngs G. R., Finn R. Food intolerance, atopy, and irritable bowel syndrome. // Lancet.- 1985.-Vol. 2.-P. 1064.
16. Lillestol, K., Helgeland, L., Lied, G. et al. Indications of «atopic bowel» in patients with self-reported food hypersensitivity // Aliment. Pharmacol. Ther.-2010. - Vol. 31. - P. 1112-1122.
17. Lee H., Park J., Park D. et al. Mucosal mast cell count is associated with intestinal permeability in patients with diarrhea predominant irritable bowel syndrome. // J. Neurogastroenterol. Motil.- 2013.- Vol. 19.- P. 244-250.
18. Deiteren A., De Man J. G., Pelckmans P. A. et al. Histamine H4 receptors in the gastrointestinal tract. // British J. of Pharmacology.- 2015. - Vol. 172, No. 5. - P. 1165-1178.
19. Coruzzi G., Adami M., Pozzoli C. Role of histamine H4 receptors in the gastrointestinal tract. // Front Biosci. (Schol. Ed.) - 2012.- Vol. 4.- P. 226-239.
20. Barbara G., Stanghellini V., De Giorgio. et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. // Gastroenterology.- 2004.- Vol. 126.- P. 693-702.
21. Klooker T., Braak B., Koopman K. O. et al. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome. // Gut. - 2010.- Vol. 59.- P. 12131221.
22. Крылова С. Г., Разина Т. Г., Зуева Е. П. и др. Анальгезирующая и противовоспалительная активность антител к гистамину в эксперименте. // Бюл. экспер. биол. и медицины. - 2002. - Прил. 4. - С. 95-97.
23. Маев И. В., Самсонов А. А., Яшина А. В. и др. Клиническая эффективность и безопасность схем лечения синдрома раздраженного кишечника (результаты сравнительного исследования). // Consilium Medicum. - 2016.- Т. 18, № 8.- С. 19-26.
24. Эпштейн О. И., Пашинский В. Г., Зеленская К. Л. и др. Противовоспалительное и обезболивающее действие гомеопатического препарата антител к фактору некроза опухоли-а // Бюллетень экспериментальной биологии и медицины.- 2001.- Прил.3.- С. 57-59
25. Savage J., Courneya J., Sterba P. et al. Kinetics of mast cell, basophil, and oral food challenge responses in omalizumab-treated adults with peanut allergy. // J. Allergy Clin. Immunol.-2012.- Vol. 130.- P. 1123.
26. Kamisawa T., Zen Y., Pillai S., Stone J. H. IgG4-related disease. // Lancet.- 2015.- Vol. 385.- P. 1460-1471.
27. Shanahan F., Whorwell P. J. IgG-mediated food intolerance in irritable bowel syndrome: a real phenomenon or an epiphenomenom ? // Am. J. Gastroenterol.- 2005.- Vol. 100. - P. 1558-1559.
28. Zar S., Mincher L., Benson M. J., Kumar D. Food-specific IgG4 antibody-guided exclusion diet improves symptoms and rectal compliance in irritable bowel syndrome. // Scand. J. Gastroenterol.-2005.- Vol. 40.- P. 800-807.
29. Aydinlar E. I., Dikmen P. Y., Tiftikci A et al. IgG-based elimination diet in migraine plus irritable bowel syndrome. // Headache.- 2013.- Vol. 53. - P. 514-525.
Review
For citations:
Akhmedov V.A., Gaus O.V. Participation of allergic mechanisms in formation of irritable bowel syndrome. Medical alphabet. 2018;3(30):5-8. (In Russ.)
Views:
268
Email this article 